Table 2.
Group | Patient number (%) |
|||||
---|---|---|---|---|---|---|
Hemoglobin deficiency (Men < 13 g/dL, women < 12 g/dL) | Iron deficiency (<60 μg/dL) | Vitamin B12 deficiency (<200 pg/mL) | Folic acid deficiency (<4 ng/mL) | Hyperhomocysteinemia (>12.3 μM) | GPCA positivity | |
BMS patients with microcytosis (n = 68) | 50 (73.5) | 30 (44.1) | 3 (4.4) | 2 (2.9) | 9 (13.2) | 7 (10.3) |
aP-value | <0.001 | <0.001 | <0.001 | 0.010 | <0.001 | <0.001 |
bP-value | <0.001 | <0.001 | 0.873 | 0.974 | 0.252 | 0.734 |
BMS patients without microcytosis (n = 816) | 125 (15.3) | 113 (13.8) | 39 (4.8) | 18 (2.2) | 161 (19.7) | 102 (12.5) |
aP-value | <0.001 | <0.001 | <0.001 | 0.004 | <0.001 | <0.001 |
Healthy control subjects (n = 442) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 11 (2.5) | 8 (1.8) |
Comparisons of frequencies of parameters between 68 BMS patients with microcytosis or 816 BMS patients without microcytosis and 442 healthy control subjects by chi-square or Fisher's exact test, where appropriate.
Comparisons of frequencies of parameters between 68 BMS patients with microcytosis and 816 BMS patients without microcytosis by chi-square or Fisher's exact test, where appropriate.